Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants
Corresponding Author
H. Zreiqat
School of Pathology, UNSW, Sydney 2052, Australia
School of Pathology, UNSW, Sydney 2052, AustraliaSearch for more papers by this authorC. R. Howlett
School of Pathology, UNSW, Sydney 2052, Australia
Search for more papers by this authorA. Zannettino
Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, Australia
Search for more papers by this authorG. Schulze-Tanzil
Institute for Anatomy, Benjamin Franklin Medical Center, Free University of Berlin, Berlin, Germany
Search for more papers by this authorC. Knabe
Department of Experimental Dentistry, University Hospital Benjamin Franklin, Free Univesity of Berlin, Berlin, Germany
Search for more papers by this authorM. Shakibaei
Institute for Anatomy, Benjamin Franklin Medical Center, Free University of Berlin, Berlin, Germany
Search for more papers by this authorCorresponding Author
H. Zreiqat
School of Pathology, UNSW, Sydney 2052, Australia
School of Pathology, UNSW, Sydney 2052, AustraliaSearch for more papers by this authorC. R. Howlett
School of Pathology, UNSW, Sydney 2052, Australia
Search for more papers by this authorA. Zannettino
Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, Australia
Search for more papers by this authorG. Schulze-Tanzil
Institute for Anatomy, Benjamin Franklin Medical Center, Free University of Berlin, Berlin, Germany
Search for more papers by this authorC. Knabe
Department of Experimental Dentistry, University Hospital Benjamin Franklin, Free Univesity of Berlin, Berlin, Germany
Search for more papers by this authorM. Shakibaei
Institute for Anatomy, Benjamin Franklin Medical Center, Free University of Berlin, Berlin, Germany
Search for more papers by this authorAbstract
Poor cell adhesion to orthopaedic and dental implants may result in implant failure. Cellular adhesion to biomaterial surfaces primarily is mediated by integrins, which act as signal transduction and adhesion proteins. Because integrin function depends on divalent cations, we investigated the effect of magnesium ions modified bioceramic substrata (Al2O3-Mg2+) on human bone-derived cell (HBDC) adhesion, integrin expression, and activation of intracellular signalling molecules. Immunohistochemistry, flow cytometry, cell adhesion, cell adhesion blocking, and Western blotting assays were used. Our findings demonstrated that adhesion of HBDC to Al2O3-Mg2+ was increased compared to on the Mg2+-free Al2O3. Furthermore, HBDC adhesion decreased significantly when the fibronectin receptor α5β1- and β1-integrins were blocked by functional blocking antibodies. HBDC grown on the Mg2+-modified bioceramic expressed significantly enhanced levels of β1-, α5β1-, and α3β1-integrins receptors compared to those grown on the native unmodified Al2O3. Tyrosine phosphorylation of intracellular integrin-dependent signalling proteins as well as the expression of key signalling protein Shc isoforms (p46, p52, p66), focal adhesion kinase, and extracellular matrix protein collagen type I were significantly enhanced when HBDC were grown on Al2O3-Mg2+ compared to the native Al2O3. We conclude that cell adhesion to biomaterial surfaces is probably mediated by α5β1- and β1-integrin. Cation-promoted cell adhesion depends on 5β1- and β1-integrins associated signal transduction pathways involving the key signalling protein Shc and results also in enhanced gene expression of extracellular matrix proteins. Therefore, Mg2+ supplementation of bioceramic substrata may be a promising way to improve integration of implants in orthopaedic and dental surgery. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 62: 175–184, 2002
References
- 1Howlett CR, Zreiqat H, Wu Y, McFall DW, McKenzie DR. Effect of ion modification of commonly used orthopedic materials on the attachment of human bone-derived cells. J Biomed Mater Res 1999; 45: 345–354.
10.1002/(SICI)1097-4636(19990615)45:4<345::AID-JBM9>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- 2Zreiqat H, Evans P, Howlett CR. Effect of surface chemical modification of bioceramic on phenotype of human bone-derived cells. J Biomed Mater Res 1999; 44: 389–396.
10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- 3Bilek MMM, Evans P, McKenzie DR, Mcculloch DG, Zreiqat H, Howlett CR. Metal ion implantation using a filtered cathodic vacuum arc. J Appl Physics 2000; 87: 4198–4204.
- 4Howlett CR, Chen N, Zhang X, Akin FA, Haynes D, Hanley L, Revell P, Evans P, Zhou H, Zreiqat H. Effect of biomaterial chemistries on the osteoblastic molecular phenotype and osteogenesis: in vitro and in vivo studies. In: JE Davies, editor. Bone tissue engineering. Toronto: Em Squared Incorporated; 2000. p 240–255.
- 5Anast CS, Mohs JM, Kaplan SL, Burns TW. Evidence for parathyroid failure in magnesium deficiency. Science 1972; 177: 606–608.
- 6Lansdown AB. Zinc in the healing wound. Lancet 1996; 347: 706–707.
- 7Gronowicz G, McCarthy MB. Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 1996; 14: 878–887.
- 8Rezania A, Healy KE. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999; 17: 615–623.
- 9Albelda SM and Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4: 2868–2880.
- 10Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11–25.
- 11Gailit J and Ruoslahti E. Regulation of the fibronectin receptor affinity by divalent cations. J Biol Chem 1988; 263: 12927–12932.
- 12Bazzoni G, Shih DT, Buck CA, Hemler ME. Monoclonal antibody 9EG7 defines a novel beta 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. J Biol Chem 1995; 270: 25570–25577.
- 13Mould AP, Akiyama SK, and Humphries MJ. Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+. J Biol Chem 1995; 270: 26270–26277.
- 14Bazzoni G, Ma L, Blue ML, Hemler ME. Divalent cations and ligands induce conformational changes that are highly divergent among beta1 integrins. J Biol Chem 1998; 273: 6670–6678.
- 15Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, and Assoian RK. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 1996; 133: 391–403.
- 16van der Flier A and Sonnenberg A. Structural and functional aspects of filamins. Biochim Biophys Acta 2001; 1538: 99–117.
- 17Longhurst CM and Jennings LK. Integrin-mediated signal transduction. Cell Mol Life Sci 1998; 54: 514–526.
- 18Damsky CH. Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 1999; 25: 95–96.
- 19Hildebrand JD, Shalter MD, Parsons JT. Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell 1995; 6: 637–647.
- 20Krause A, Cowles EA, Gronowicz G. Integrin-mediated signaling in osteoblasts on titanium implant materials. J Biomed Mater Res 2000; 52: 738–747.
- 21Cowles EA, Brailey LL, and Gronowicz GA. Integrin-mediated signaling regulates AP-1 transcription factors and proliferation in osteoblasts. J Biomed Mater Res 2000; 52: 725–737.
- 22Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 1996; 87: 733–743.
- 23Shakibaei M, John T, De Souza P, Rahmanzadeh R, Merker HJ. Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor. Biochem J 1999b; 342 Pt 3: 615–623.
- 24O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047–1059.
- 25Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995; 131: 791–805.
- 26Schwartz MA, Schaller MD, and Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995; 11: 549–599.
- 27Brown IG, Gavin JE, Gavin BF, and MacGill RA. Metal vapour vacuum arc ion source. Rev Sci Instru 1986; 57: 1069–1084.
- 28Zreiqat H, Markovic B, Walsh WR, Howlett CR. A novel technique for quantitative detection of mRNA expression in human bone derived cells cultured on biomaterials. J Biomed Mater Res 1996; 33: 217–223.
10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 29Gronthos S, Stewart K, Graves SE, Hay S, and Simmons PJ. Integrin expression and function on human osteoblast-like cells. J Bone Miner Res 1997; 12: 1189–1197.
- 30Ruoslahti E, Hayman EG, Pierschbacher M, Engvall E. Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol 1982; 82: 803–831.
- 31Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994; 84: 4164–4173.
- 32Shakibaei M, Merker H.-J.. Beta1-integrins in the cartilage matrix. Cell Tissue Res 1999a; 296: 565–573.
- 33Shakibaei M, Stahlmann R. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch Toxicol 2001a; 75: 97–102.
- 34Akiyama SK, Olden K, and Yamada KM. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev 1995; 14: 173–189.
- 35Ruoslahti E. Integrins as signaling molecules and targets for tumor therapy. Kidney Int 1997; 51: 1413–1417.
- 36Forster C, Kociok K, Shakibaei M, Merker HJ, Vormann J, Gunther T, and Stahlmann R. Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats. Arch Toxicol 1996; 70: 261–270.
- 37Stahlmann R, Kuhner S, Shakibaei M, Flores J, Vormann J, van Sickle DC. Effects of magnesium deficiency on joint cartilage in immature beagle dogs: immunohistochemistry, electron microscopy, and mineral concentrations. Arch Toxicol 2000; 73: 573–580.
- 38Ni H, Li A, Simonsen N, Wilkins JA. Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain. J Biol Chem 1998; 273: 7981–7987.
- 39Dedhar S, Argraves WS, Suzuki S, Ruoslahti E, Pierschbacher MD. Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp-containing peptide overproduce the fibronectin receptor. J Cell Biol 1987; 105: 1175–1182.
- 40Moursi AM, Globus RK, Damsky CH. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 1997; 110: 2187–2196.
- 41Takamatsu Y, Simmons PJ, Levesque JP. Dual control by divalent cations and mitogenic cytokines of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity expressed by human hemopoietic cells. Cell Adhes Commun 1998; 5: 349–366.
- 42Hughes DE, Salter DM, Dedhar S, Simpson R. Integrin expression in human bone. J Bone Miner Res 1993; 8: 527–533.
- 43Grzesik WJ, Robey PG. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 1994; 9: 487–496.
- 44Saito T, Albelda SM, Brighton CT. Identification of integrin receptors on cultured human bone cells. J Orthop Res 1994; 12: 384-394.
- 45Whittard JD and Akiyama SK. Activation of beta1 integrins induces cell-cell adhesion. Exp Cell Res 2001; 263: 65–76.
- 46George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, and Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993; 119: 1079–1091.
- 47Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, and Yamamoto T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995a; 377: 539–544.
- 48Tahiliani PD, Singh L, Auer KL, LaFlamme SE. The role of conserved amino acid motifs within the integrin beta3 cytoplasmic domain in triggering focal adhesion kinase phosphorylation. J Biol Chem 1997; 272: 7892–7898.
- 49Schlaepfer DD, Hanks SK, Hunter T, and van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786–791.
- 50Shakibaei M, Schulze-Tanzil G, de Souza P, John T, Rahmanzadeh M, Rahmanzadeh R, and Merker HJ. Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes. J Biol Chem 2001b; 276: 13289–13294.
- 51Stahlmann R, Forster C, Shakibaei M, Vormann J, Gunther T, and Merker HJ. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother 1995; 39: 2013–2018.
- 52Loeser RF. Modulation of integrin-mediated attachment of chondrocytes to extracellular matrix proteins by cations, retinoic acid, and transforming growth factor beta. Exp Cell Res 1994; 211: 17–23.
- 53Silver IA, Murrills RJ, and Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988; 175: 266–276.